DCM
PFE icon

Destrier Capital Management’s Pfizer PFE Stock Holding History

Destrier Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-221,340
Closed -$7.11M – 9
2016
Q3 		$7.11M Hold
221,340
– – 4.94% 7
2016
Q2 		$7.39M Sell
221,340
-105,400
-32% -$3.36M 4.94% 7
2016
Q1 		$9.19M Buy
+326,740
New +$9.33M 6.64% 6

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Destrier Capital Management's PFE Position: Q4 2016 in Review

Destrier Capital Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 221,340 shares — an estimated $7.11M sold.

Destrier Capital Management first reported a position in PFE in Q1 2016 and held it in 3 quarters. The position peaked at $9.19M in Q1 2016. 2,060 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Destrier Capital Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Destrier Capital Management sold 221,340 Pfizer shares in Q4 2016, an estimated $7.11M.
  • Destrier Capital Management first reported a position in Pfizer in Q1 2016 and held it in 3 quarters.
  • Destrier Capital Management's Pfizer position peaked at $9.19M in Q1 2016.
  • 2,060 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Destrier Capital Management's 13F filing for Q4 2016.